Advertisement
Australia markets open in 9 hours 31 minutes
  • ALL ORDS

    7,974.80
    -27.70 (-0.35%)
     
  • AUD/USD

    0.6618
    -0.0020 (-0.30%)
     
  • ASX 200

    7,724.30
    -25.40 (-0.33%)
     
  • OIL

    78.49
    -0.13 (-0.17%)
     
  • GOLD

    2,348.40
    +30.40 (+1.31%)
     
  • Bitcoin AUD

    100,803.45
    +634.73 (+0.63%)
     
  • CMC Crypto 200

    1,385.11
    -32.76 (-2.31%)
     

Pfizer (PFE) Recently Broke Out Above the 200-Day Moving Average

From a technical perspective, Pfizer (PFE) is looking like an interesting pick, as it just reached a key level of support. PFE recently overtook the 200-day moving average, and this suggests a long-term bullish trend.

The 200-day simple moving average is widely-used by traders and analysts, and helps establish market trends for stocks, commodities, indexes, and other financial instruments over the long term. The indicator moves higher or lower together with longer-term price moves, serving as a support or resistance level.

Over the past four weeks, PFE has gained 12.7%. The company is currently ranked a Zacks Rank #3 (Hold), another strong indication the stock could move even higher.

The bullish case solidifies once investors consider PFE's positive earnings estimate revisions. No estimate has gone lower in the past two months for the current fiscal year, compared to 9 higher, while the consensus estimate has increased too.

ADVERTISEMENT

With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on PFE for more gains in the near future.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Pfizer Inc. (PFE) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research